Reuters - Video

Edition: US | UK | IN | CN | JP

video Finance Videos

Novartis to buy AveXis in $8.7bn gene-therapy deal

Monday, April 09, 2018 - 01:28

Swiss drugmaker Novartis is moving further into gene therapy by buying AveXis for $8.7 billion, adding a rare-disease treatment that could reap billions in sales. Kate King reports.

▲ Hide Transcript

View Transcript

Swiss drugmaker Novartis is moving further into gene therapy by buying AveXis for $8.7 billion, adding a rare-disease treatment that could reap billions in sales. Kate King reports.

Press CTRL+C (Windows), CMD+C (Mac), or long-press the URL below on your mobile device to copy the code

Novartis to buy AveXis in $8.7bn gene-therapy deal

Monday, April 09, 2018 - 01:28